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Editorial Comment 
"Rush-a-Homa": Is a Shorter 
Hospital Stay Better 
for the Patient?* 
ARTHUR J. MOSS, MD, FACC 
Rochester, New York 
The economic and administrative pressures that are sweeping 
the country to reduce medical care costs are focused on 
shortening the length of hospital stay. This is the case whether 
it is for managing patients with acute myocardial infarction, 
congestive heart failure or complex ventricular arrhythmias, or, 
for that matter, for patients admitted to the hospital with 
almost any medical problem or surgical procedure. At every 
hospital throughout he country, departmental staffs are 
spending an increasing amount of time developing practice 
guidelines on how to shorten the hospital stay of patients with 
various disease ntities. These questions are now taking prior- 
ity over issues that relate to the quality and excellence of 
medical care. The focus has shifted from the individual patient 
and his or her medical condition to percentages and length of 
hospital stay. Within the first 24 h of a patient entering the 
hospital with an acute myocardial infarction, a considerable 
amount of pressure is placed on the attending physician and 
consulting cardiologist to plan for early discharge. I refer to 
these pressures as the "rush-a-homa" attitude. 
Present study. In this issue of the Journal, the elegant 
descriptive article by Every et al. (1) deals with factors 
influencing length of hospital stay after acute myocardial 
infarction in 19 Seattle-area hospitals over a 5-year period and 
highlights the dilemma in which we find ourselves. Although 
various patient characteristics, medical problems during the 
hospital stay and procedure use (angiography, angioplasty, 
coronary bypass surgery) were related to the duration of 
hospital stay, none of the measured factors explained the 28% 
reduction in hospital stay between 1988 and 1994 in the Seattle 
hospitals. In addition, the measured factors accounted for only 
33% of the observed variation in the length of stay. That is, 
67% of the variation is not explained by the large number of 
collected variables. The unidentified factors, including the 
intangible, difficult to measure conomic pressures, are surely 
contributing to a shortened hospital stay after acute myocar- 
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dial infarction. How does one measure the "rush-a-homa" 
pressures? 
Is a shortened hospital stay after acute myocardial infarc- 
tion beneficial to the patient? This is a terribly important 
question, and it demands an answer before we accept further 
shortening of the hospital period. What is the subsequent 
morbidity, mortality and quality-of-life of patients discharged 
very early (3 to 4 days) after an acute myocardial infarction? In 
1988, Topol et al. (2) reported on the posthospital course of 80 
patients without angina, heart failure, arrhythmias or provo- 
cable myocardial ischemia on exercise testing who were ran- 
domly assigned to very early (day 3) or conventional (day 7 to 
10) hospital discharge after myocardial infarction. At 6 months 
of follow-up, the 45 good risk patients in each group had 
similar favorable outcomes. Topoi et al. (2) cautiously com- 
mented that "before this strategy can be widely recommended 
... its safety must be confirmed in larger prospective clinical 
trials." The study by Every et al. (1) was not a clinical trial, and 
the Myocardial Triage and Intervention (MITI) registry of 
almost 20,000 patients has not been used to evaluate the safety 
implications of the 28% reduction in hospital stay between 
1988 and 1994. Are our diagnostic and evaluative tests and 
procedures good enough to identi~ subclinical risk problems 
in "good risk" patients during an attenuated hospital stay? 
What is the rate of hospital readmission among patients 
discharged very early after infarction? There are good risk 
patients who die unexpectedly after early hospital discharge, 
and one wonders whether they would have survived had they 
been observed in the hospital a little longer. These infrequent 
mortality events in good risk patients would not show up in 
overall mortality rates. Once again, are we doing the best for 
our patients by succumbing to the "rush-a-homa" pressures? 
How short is short, and is shorter better? During the past 30 
years, the hospital stay for acute myocardial infarction has 
been reduced, on average, from 3 weeks to <1 week. We have 
better cardiac therapy now than in the past. Acutely occluded 
coronary arteries can be revascularized bythrombolytic agents, 
primary angioplasty or coronary bypass surgery. Infarct size 
can be reduced by these emergency procedures; adverse 
myocardial remodeling can be attenuated by angiotensin- 
converting enzyme (ACE) inhibitors; and beta-adrenergic 
blocking agents can improve short- as well as long-term 
survival. Can all these therapies be safely administered in <1 
week, and can we still respond to the emotional concerns of the 
patient and his or her family after an acute coronary event? No 
two patients have the same fingerprint, and no two patients 
respond to the same drug in the same way. With the current 
hospital stay < 1 week, and the anticipation that the length of 
stay will be even shorter in the future, three therapeutic 
questions must be asked: 1) ls very early initiation of prophy- 
lactic therapy with a vasoactive agent such as an ACE inhibitor 
as safe on day 1 or 2 after an acute myocardial infarction as it 
is on day 4 or 5? 2) Is monitoring of the response to the 
initiation of an ACE inhibitor as safe at home after early 
discharge as it is in the hospital? 3) Does the "rush-a-homa" 
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pressure compromise our ability to deliver the best care to 
each individual patient? 
The "rush-a-homa" pressures extend to all medical disci- 
plines. We are all aware of the 24-h discharge policy for mother 
and child after an uncomplicated delivery and the consterna- 
tion it has produced among pediatricians responsible for the 
evaluation and care of the newborn. Simply put, 24 h is simply 
too short a time for assessing the risk potential of the newborn. 
Only after several infant deaths occurred after early discharge 
and were reported by the news media were the pediatricians 
and parents effective in lobbying state governments o pass 
laws requiring a minimum of 48 h of observation of the 
newborn before hospital discharge. Obviously, the impetus for 
increasing the length of the hospital stay did not come from the 
insurance companies. As cardiologists, do we think it is in the 
best interests of our patients to shorten their hospital stay even 
further after an acute myocardial infarction to reduce costs to 
insurance companies, for-profit health maintenance organiza- 
tions (HMOs) and industry? When does "reduce the cost" 
philosophy result in inappropriate "rush-a-homa?" 
The analysis of the MITI registry on length of stay after 
myocardial infarction provides the best contemporary quanti- 
tative data on the evolving changes that are taking place in the 
delivery of health care to patients with acute coronary disease. 
The superb article by Every et al. identifies where we are and 
possibly where we are going, but the scientific underpinnings of 
the progressively shortened hospital stay after myocardial 
infarction are unclear. The duration of the hospital stay after 
myocardial infarction should be based on good science, and we 
should not accept he "rush-a-homa" pproach without data 
from a properly designed, prospective trial. Further shortening 
of the hospital stay will obviously reduce hospital costs, but 
such cost savings are not necessarily ifesaving and may not be 
in the best interests of the patient. 
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